SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-22-000015
Filing Date
2022-11-10
Accepted
2022-11-10 17:06:43
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20220930.htm   iXBRL 10-Q 1275122
2 EX-31.1 vtvt-20220930xexx311.htm EX-31.1 10213
3 EX-31.2 vtvt-20220930xexx312.htm EX-31.2 10427
4 EX-32.1 vtvt-20220930xexx321.htm EX-32.1 5021
5 EX-32.2 vtvt-20220930xexx322.htm EX-32.2 4988
11 vtvt-20220930_g1.jpg GRAPHIC 213466
  Complete submission text file 0001641489-22-000015.txt   6787255

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20220930.xsd EX-101.SCH 53540
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20220930_cal.xml EX-101.CAL 51769
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20220930_def.xml EX-101.DEF 302504
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20220930_lab.xml EX-101.LAB 583477
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20220930_pre.xml EX-101.PRE 381010
63 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20220930_htm.xml XML 952021
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 221378442
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences